一个QSP PDE模型的ADC运输和动力学在一个成长或缩小的瘤
1Eisai Inc., Nutley, NJ, USA. david_ross@eisai.com.
Journal of pharmacokinetics and pharmacodynamics
|October 19, 2025
概括
抗体-药物联合体 (ADC) 治疗瘤,但瘤结构的变化会影响治疗. 在动态瘤中模拟ADC动力学揭示了非单调增长抑制和同时服用抗体的时间依赖性影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 数学生物学 数学生物学
- 在瘤学瘤学.
背景情况:
- 瘤微环境是动态的,在抗体 - 药物合剂 (ADC) 治疗期间改变大小,结构和细胞活力.
- 瘤细胞的增殖,损伤,清除和抗原表达波动,影响ADC的疗效.
- 定量系统药理学 (QSP) 需要建模这些动态变化,以准确预测治疗.
研究的目的:
- 开发一个部分微分方程 (PDE) 模型模拟ADC运输和动力学在一个动态的克罗格圆柱体瘤.
- 研究瘤大小和结构演变对ADC治疗结果的影响.
- 分析抗原度与瘤生长抑制之间的关系,以及同时服用单克隆抗体 (mAbs) 的影响.
主要方法:
- 开发了一个PDE模型来表示ADC药理动力学和药理动力学在一个成长和缩小的克罗格圆柱瘤模型.
- 在瘤结构和抗原表达的不同条件下,模拟瘤对ADC治疗的反应.
- 进行了计算研究,以评估抗原度和联合使用的mAb时间对治疗疗效的影响.
主要成果:
- 瘤生长抑制表明与抗原度有非单一的关系.
- 同时使用mAb和ADC显示有效性降低,并增加了两次注射之间的延迟.
- 该模型阐明了mAb和ADC治疗同时使用的时间依赖作用背后的机制.
结论:
- 建模动态瘤变化对于理解ADC治疗反应至关重要.
- 抗原度和治疗干预的时间显著影响ADC的疗效.
- 开发的PDE模型为优化基于ADC的癌症疗法提供了有价值的工具.
相关概念视频
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
232
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
232
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
309
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
309
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
241
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
241
01:26Pharmacokinetic Models: Comparison and Selection Criterion
301
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
301
01:14Active Transport
1.9K
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
1.9K